Inhibitory Effect of Lactococcus and Enterococcus faecalis on Citrobacter Colitis in Mice

Ullah Naveed,Chenxi Jiang,Qingsong Yan,Yupeng Wu,Jinhui Zhao,Bowen Zhang,Junhong Xing,Tianming Niu,Chunwei Shi,Chunfeng Wang
DOI: https://doi.org/10.3390/microorganisms12040730
IF: 4.5
2024-04-03
Microorganisms
Abstract:Probiotics are beneficial for intestinal diseases. Research shows that probiotics can regulate intestinal microbiota and alleviate inflammation. Little research has been done on the effects of probiotics on colitis in mice. The purpose of this study was to investigate the inhibitory effect of the strains isolated and screened from the feces of healthy piglets on the enteritis of rocitrobacter. The compound ratio of isolated Lactobacillus L9 and Enterococcus faecalis L16 was determined, and the optimal compound ratio was selected according to acid production tests and bacteriostatic tests in vitro. The results showed that when the ratio of Lactobacillus L9 to Enterococcus faecalis L16 was 4:1, the pH value was the lowest, and the antibacterial diameter was the largest. Then, in animal experiments, flow cytometry was used to detect the number of T lymphocytes in the spleen and mesenteric lymph nodes of mice immunized with complex lactic acid bacteria. The results showed that the number of T lymphocytes in the spleen and mesenteric lymph nodes of mice immunized with complex lactic acid bacteria significantly increased, which could improve the cellular immunity of mice. The microbiota in mouse feces were sequenced and analyzed, and the results showed that compound lactic acid bacteria could increase the diversity of mouse microbiota. It stabilized the intestinal microbiota structure of mice and resisted the damage of pathogenic bacteria. The combination of lactic acid bacteria was determined to inhibit the intestinal colitis induced by Citrobacter, improve the cellular immune response of the body, and promote the growth of animals.
microbiology
What problem does this paper attempt to address?
The problem this paper attempts to address is the study of the inhibitory effects of Lactococcus and Enterococcus faecalis on colitis caused by Citrobacter rodentium in mice. Specifically, the researchers isolated and screened two strains of lactic acid bacteria (L9 and L16) from the feces of healthy piglets and determined the optimal composite ratio of these two strains through in vitro experiments. Then, through animal experiments, they evaluated the inhibitory effect of this composite lactic acid bacteria on colitis caused by Citrobacter rodentium infection in mice, including the effects on mouse body weight, feed intake, antioxidant capacity, cellular immune response, and gut microbiota. ### Main Research Questions: 1. **Determine the optimal composite ratio**: Determine the optimal composite ratio of Lactococcus L9 and Enterococcus faecalis L16 through in vitro experiments. 2. **Evaluate the inhibitory effect**: Evaluate the inhibitory effect of composite lactic acid bacteria on colitis caused by Citrobacter rodentium through animal experiments. 3. **Analyze physiological and immune indicators**: Assess the impact of composite lactic acid bacteria on mouse body weight, feed intake, antioxidant capacity, and cellular immune response. 4. **Study changes in gut microbiota**: Analyze the impact of composite lactic acid bacteria on the diversity of gut microbiota in mice. ### Research Background: - Citrobacter rodentium is a pathogen that can colonize the mouse colon and cause attaching and effacing (A/E) lesions, commonly used to study the development of colitis. - Lactic acid bacteria, as probiotics, can improve gut health by regulating the gut microbiota and inhibiting the growth of harmful bacteria. ### Experimental Design: - **In vitro experiments**: Determine the optimal composite ratio of Lactococcus L9 and Enterococcus faecalis L16 through acid production tests and antibacterial tests. - **Animal experiments**: Divide mice into control group (PBS group) and experimental group (composite lactic acid bacteria group) to observe the effects of composite lactic acid bacteria on mouse body weight, feed intake, antioxidant capacity, and cellular immune response. - **Pathological analysis**: Observe the histopathological changes in the colon and duodenum of mice through tissue sections and staining. - **Gut microbiota analysis**: Analyze the diversity of gut microbiota in mice through high-throughput sequencing. ### Main Results: - **Optimal composite ratio**: When the ratio of Lactococcus L9 to Enterococcus faecalis L16 is 4:1, the acidity is the lowest and the antibacterial diameter is the largest. - **Body weight and feed intake**: Mice in the composite lactic acid bacteria group gained more weight, and feed intake slightly decreased. - **Antioxidant capacity**: The total antioxidant capacity in the serum of mice in the composite lactic acid bacteria group significantly increased. - **Cellular immune response**: The number of T lymphocytes in the spleen and mesenteric lymph nodes of mice in the composite lactic acid bacteria group significantly increased. - **Gut microbiota**: The diversity of gut microbiota in mice in the composite lactic acid bacteria group increased, the structure was stable, and it resisted the invasion of pathogenic bacteria. ### Conclusion: Composite lactic acid bacteria (L9 and L16 ratio of 4:1) can effectively inhibit colitis caused by Citrobacter rodentium, improve the cellular immune response of mice, promote animal growth, and increase the diversity of gut microbiota. This indicates that composite lactic acid bacteria have a good probiotic effect and are expected to be an alternative strategy to antibiotics.